BioAtla | Investor Presentation Deck | 55 slides · page 55 of 55
Uses a Venn-like diagram to connect technology, pipeline, and financial status.
Pitch deck · executive_summary · summarize · balanced density
Slide locked Sign in to view
Slide schematic 2/2
diagram 1/1 title 1/1
Components 2
venn headline
Tools 2
Executive summary slide · 90%
BioAtla is a clinical stage company focused on transforming cancer therapy with Conditionally Active Biologics (CABs)
Venn diagram slide · 70%Proprietary technology, Broad applicability in solid tumors, Increases therapeutic window, Two Phase 2 CAB-ADCs, one Phase 2 CAB-CTLA-4 and one Phase 1 dual CAB-bispecific T-cell engager, CAB-AXL-ADC (BA301
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.